US Stock MarketDetailed Quotes

SHC Sotera Health Company

Watchlist
  • 11.810
  • -0.350-2.88%
Close Mar 10 16:00 ET
  • 11.980
  • +0.170+1.44%
Pre 04:14 ET
3.35BMarket Cap73.81P/E (TTM)

About Sotera Health Company Company

Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. It also provides end-to-end sterilization as well as microbiological and analytical lab testing and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients and consumers. The firm operates through the following businesses: Sterigenics, Nordion, and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets by using following technologies: gamma irradiation, EO processing and E-beam irradiation. The Nordion business provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process. The Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was founded in 1978 and is headquartered in Broadview Heights, OH.

Company Profile

SymbolSHC
Company NameSotera Health Company
Listing DateNov 20, 2020
Issue Price23.00
Founded1978
CEOMr. Michael B. Petras, Jr
MarketNASDAQ
Employees3000
Fiscal Year Ends12-31
Address9100 South Hills Boulevard,Suite 300
CityBroadview Heights
ProvinceOhio
CountryUnited States of America
Zip Code44147-3518
Phone1-440-262-1410

Company Executives

  • Name
  • Position
  • Salary
  • Michael B. Petras, Jr
  • Chairman of the Board and Chief Executive Officer
  • 9.70M
  • Jonathan M. Lyons
  • Senior Vice President, Chief Financial Officer and Principal Accounting Officer
  • 2.18M
  • Alexander Dimitrief
  • Senior Vice President and General Counsel
  • 862.18K
  • Michael P. Rutz
  • President of Sterigenics
  • 2.03M
  • Vincent K. Petrella
  • Independent Director
  • 325.00K
  • Sean L. Cunningham
  • Independent Director
  • 302.50K
  • James C. Neary
  • Independent Director
  • 320.00K
  • Christopher A. Simon
  • Independent Director
  • --
  • Karen A. Flynn
  • Independent Director
  • 9.99K
  • Ruoxi Chen
  • Independent Director
  • 302.50K
  • Robert B. Knauss
  • Independent Director
  • 300.00K
  • Constantine S. Mihas
  • Independent Director
  • 305.00K
  • Ann R. Klee
  • Independent Director
  • 322.50K
  • Dr. David E. Wheadon
  • Independent Director
  • 310.00K

Trending Stocks

U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More